|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2004-4-19
|
|
pubmed:abstractText |
To examine the effect of adding nevirapine (NVP) and/or hydroxyurea (HU) to a triple nucleoside analogue reverse transcriptase inhibitor (NRTI) regimen in terms of efficacy and tolerability.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0269-9370
|
|
pubmed:author |
pubmed-author:BeniowskiMarekM,
pubmed-author:BlanckenbergDaniel HDH,
pubmed-author:Boron-KaczmarskaAnnaA,
pubmed-author:CHARM Study Group,
pubmed-author:FatkenheuerGG,
pubmed-author:HalotaWaldemarW,
pubmed-author:HorbanAndrzejA,
pubmed-author:JessenHeikoH,
pubmed-author:LangeJoep M AJM,
pubmed-author:SchmidtReinhold ERE,
pubmed-author:TrochaHannaH,
pubmed-author:WoodRobinR
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
5
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
631-40
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15090768-Adult,
pubmed-meshheading:15090768-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:15090768-CD4 Lymphocyte Count,
pubmed-meshheading:15090768-Female,
pubmed-meshheading:15090768-HIV Infections,
pubmed-meshheading:15090768-HIV-1,
pubmed-meshheading:15090768-Humans,
pubmed-meshheading:15090768-Hydroxyurea,
pubmed-meshheading:15090768-Male,
pubmed-meshheading:15090768-Middle Aged,
pubmed-meshheading:15090768-Nevirapine,
pubmed-meshheading:15090768-RNA, Viral,
pubmed-meshheading:15090768-Reverse Transcriptase Inhibitors,
pubmed-meshheading:15090768-Treatment Failure,
pubmed-meshheading:15090768-Treatment Outcome,
pubmed-meshheading:15090768-Viral Load
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Evaluation of nevirapine and/or hydroxyurea with nucleoside reverse transcriptase inhibitors in treatment-naive HIV-1-infected subjects.
|
|
pubmed:affiliation |
International Antiviral Therapy Evaluation Center, Departmernt of Human Retrovirology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
